India has supplied COVID-19 vaccines to Cambodia and Thailand as part of an initiative of the Quad group of countries, New Delhi said on Thursday, although Johnson & Johnson did not shoot down as originally planned.
The leaders of the Quad countries – India, the United States, Japan and Australia – may meet in Japan on Tuesday to discuss a vaccine supply plan, Indian Foreign Ministry spokesman Arindam Bagchi told a news conference.
Read the latest updates in our dedicated Coronavirus section,
“We have sent vaccines to Cambodia and Thailand under the quad umbrella,” Bagchi said.
For the latest headlines, follow our Google News Channel online or through the app,
“Yes, the original plan was to use a different modality, but the ultimate aim is to ensure that vaccines under the quad umbrella are shared among countries that need them.”
Bagchi didn’t give numbers, but data from the Indian Ministry of External Affairs shows India shipped 200,000 doses of Kovovax last month,
A version of the Novavax vaccine made by the Serum Institute of India (SII) to Thailand under the Quad programme.
Data shows India separately shipped 325,000 doses of Covishield, a version of the AstraZeneca shot made by SII, to Cambodia.
Quad was originally to be supplied by Indian company Biological E Ltd to supply J&J supplements to Southeast Asian and others
countries, as a counter to China’s vaccine donations around the world.
Organic E did not immediately respond to a request for comment. Reuters could not immediately contact J&J.
Read more: India hits 1 billion COVID-19 vaccine doses